<p>Meeder Asset Management Inc. 在第三季度增加了對 Elevance Health, Inc. (NYSE:ELV - 免費報告) 的持股，增幅達到 31,029.4%，根據其最近向 SEC 的披露。這家機構投資者在該期間額外購買了 15,825 股後，持有該公司 15,876 股股票。根據其最近的 SEC 文件，Meeder Asset Management Inc. 在 Elevance Health 的持股價值為 5,130,000 美元。</p>
<p>獲取 <strong>Elevance Health</strong> 警報：</p>
<ul>
<li>這隻 ETF 證明了醫療保健反彈是真實的</li>
</ul>
<p>其他一些對沖基金最近也對該股票的持倉進行了調整。Vanguard Group Inc. 在第二季度將其在 Elevance Health 的持倉提高了 3.2%。Vanguard Group Inc. 目前持有該公司 22,856,898 股股票，價值 8,890,419,000 美元，在上個季度額外購買了 704,790 股。Sanders Capital LLC 在第二季度將其在 Elevance Health 的股份提高了 24.7%。Sanders Capital LLC 目前持有該公司 5,825,208 股股票，價值 2,265,773,000 美元，在上個季度額外購買了 1,152,440 股。Artisan Partners Limited Partnership 在第二季度將其在 Elevance Health 的持股增加了 9.7%。Artisan Partners Limited Partnership 目前持有該公司 3,675,179 股股票，價值 1,429,498,000 美元，在上個季度額外購買了 324,399 股。挪威銀行在第二季度購買了 Elevance Health 的新股份，價值 1,148,379,000 美元。最後，The Manufacturers Life Insurance Company 在第二季度將其在 Elevance Health 的持股提高了 30.7%。The Manufacturers Life Insurance Company 目前持有該公司 2,076,668 股股票，價值 807,741,000 美元，在上個季度額外購買了 487,579 股。89.24% 的股票由機構投資者持有。</p>
<h2>Elevance Health 價格表現</h2>
<p>Elevance Health 股票週一開盤價為 372.80 美元。該公司的 50 日移動平均線為 338.20 美元，200 日移動平均線為 327.98 美元。該公司的速動比率為 1.56，流動比率為 1.56，債務與股本比率為 0.71。該公司的市值為 828.5 億美元，市盈率為 15.24，市盈增長比率為 1.92，貝塔值為 0.51。Elevance Health, Inc. 的 52 周低點為 273.71 美元，52 周高點為 458.75 美元。</p>
<ul>
<li>防禦性投資：3 家支付股息的公司報告強勁的第三季度收益</li>
</ul>
<p>Elevance Health (NYSE:ELV - 獲取免費報告) 最近在 10 月 21 日星期二發佈了季度收益結果。該公司報告第三季度每股收益為 6.03 美元，超出分析師一致預期的 5.03 美元，超出幅度為 1.00 美元。Elevance Health 的股本回報率為 16.17%，淨利潤率為 2.84%。該公司第三季度的收入為 500.9 億美元，而分析師預期為 492.6 億美元。去年同期，該公司每股收益為 8.37 美元。Elevance Health 的季度收入同比增長 12.0%。研究分析師平均預計 Elevance Health, Inc. 本財年將發佈 33.96 的每股收益。</p>
<h2>Elevance Health 宣佈分紅</h2>
<p>該公司最近還宣佈了季度分紅，已於 12 月 19 日星期五支付。12 月 5 日星期五的股東獲得每股 1.71 美元的分紅。這相當於年化 6.84 美元的分紅和 1.8% 的股息收益率。除息日為 12 月 5 日星期五。Elevance Health 的分紅支付比率 (DPR) 目前為 27.96%。</p>
<h2>分析師評級上調與下調</h2>
<ul>
<li>為什麼 Centene 股票下跌 40% — 現在是否值得購買</li>
</ul>
<p>幾家券商最近對 ELV 發表了評論。摩根大通將 Elevance Health 的目標價從 384.00 美元上調至 394.00 美元，並在 10 月 28 日的研究報告中給予該公司 “增持” 評級。德意志銀行重申了 “持有” 評級，並在 12 月 19 日的報告中將 Elevance Health 的目標價設定為 320.00 美元（低於 332.00 美元）。Wolfe Research 將 Elevance Health 的目標價設定為 425.00 美元，並在週四的研究報告中給予該股票 “跑贏大盤” 評級。瑞穗證券在週五的研究報告中將 Elevance Health 的目標價設定為 413.00 美元。最後，摩根士丹利在 12 月 17 日的研究報告中將 Elevance Health 的目標價從 359.00 美元下調至 352.00 美元，並對該股票給予 “持平” 評級。十三位投資分析師對該股票給予了買入評級，十一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com，該股票目前的共識評級為 “持有”，共識目標價為 400.85 美元。</p>
<p><strong>查看我們最新的 Elevance Health 股票分析</strong></p>
<h2>Elevance Health 公司簡介</h2>
<p>(免費報告)</p>
<p>Elevance Health, Inc NYSE: ELV 是一家總部位於美國的大型健康福利公司，提供廣泛的健康保險產品和相關服務。公司總部位於印第安納波利斯，2022 年從 Anthem, Inc 更名為 Elevance Health，同時繼續以既有的州和國家品牌運營面向消費者的健康計劃。Gail Boudreaux 擔任首席執行官和總裁，領導公司在綜合醫療和福利交付方面的戰略重點。</p>
<p>Elevance 的核心業務包括為個人、僱主和政府項目（包括 Medicare 和 Medicaid 管理醫療產品）提供醫療和專業健康計劃。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票超過 Elevance Health</li>
<li>華爾街 “潛力股” 可能成為 2026 年的第一隻股票</li>
<li>開火正式開始……</li>
<li>請勿刪除，立即閲讀</li>
<li>特朗普計劃使用公共法 63-43：請做好準備</li>
<li>巨大的機器人推廣正在進行中</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Elevance Health 嗎？</h2>
<p>在考慮 Elevance Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛市場注意到之前購買的股票……而 Elevance Health 並不在名單上。</p>
<p>雖然 Elevance Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Meeder Asset Management Inc. 在第三季度大幅增加了對 Elevance Health, Inc. 的持股，增幅達到 31,029.4%，額外購入了 15,825 股，使其總持股量達到 15,876 股，市值為 513 萬美元。其他機構投資者，包括先鋒集團和 Sanders Capital 也提高了在 Elevance Health 的持倉。該公司的股票開盤價為 372.80 美元，市值為 828.5 億美元，市盈率為 15.24。Elevance Health 報告第三季度每股收益為 6.03 美元，超出預期，並宣佈每股季度股息為 1.71 美元</p>

<p>Meeder Asset Management Inc. increased its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 31,029.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,876 shares of the company's stock after buying an additional 15,825 shares during the period. Meeder Asset Management Inc.'s holdings in Elevance Health were worth $5,130,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Meeder Asset Management Inc. 在第三季度增加了對 Elevance Health, Inc. (NYSE:ELV - 免費報告) 的持股，增幅達到 31,029.4%，根據其最近向 SEC 的披露。這家機構投資者在該期間額外購買了 15,825 股後，持有該公司 15,876 股股票。根據其最近的 SEC 文件，Meeder Asset Management Inc. 在 Elevance Health 的持股價值為 5,130,000 美元。</p>
</div><p>Get <strong>Elevance Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Elevance Health</strong> 警報：</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>這隻 ETF 證明了醫療保健反彈是真實的</li>
</ul>
</div><p>A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Elevance Health by 3.2% in the second quarter. Vanguard Group Inc. now owns 22,856,898 shares of the company's stock valued at $8,890,419,000 after purchasing an additional 704,790 shares during the last quarter. Sanders Capital LLC lifted its stake in shares of Elevance Health by 24.7% in the second quarter. Sanders Capital LLC now owns 5,825,208 shares of the company's stock worth $2,265,773,000 after buying an additional 1,152,440 shares in the last quarter. Artisan Partners Limited Partnership increased its holdings in Elevance Health by 9.7% in the 2nd quarter. Artisan Partners Limited Partnership now owns 3,675,179 shares of the company's stock worth $1,429,498,000 after buying an additional 324,399 shares in the last quarter. Norges Bank purchased a new stake in Elevance Health during the 2nd quarter valued at $1,148,379,000. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Elevance Health by 30.7% in the second quarter. The Manufacturers Life Insurance Company now owns 2,076,668 shares of the company's stock worth $807,741,000 after buying an additional 487,579 shares during the last quarter. 89.24% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些對沖基金最近也對該股票的持倉進行了調整。Vanguard Group Inc. 在第二季度將其在 Elevance Health 的持倉提高了 3.2%。Vanguard Group Inc. 目前持有該公司 22,856,898 股股票，價值 8,890,419,000 美元，在上個季度額外購買了 704,790 股。Sanders Capital LLC 在第二季度將其在 Elevance Health 的股份提高了 24.7%。Sanders Capital LLC 目前持有該公司 5,825,208 股股票，價值 2,265,773,000 美元，在上個季度額外購買了 1,152,440 股。Artisan Partners Limited Partnership 在第二季度將其在 Elevance Health 的持股增加了 9.7%。Artisan Partners Limited Partnership 目前持有該公司 3,675,179 股股票，價值 1,429,498,000 美元，在上個季度額外購買了 324,399 股。挪威銀行在第二季度購買了 Elevance Health 的新股份，價值 1,148,379,000 美元。最後，The Manufacturers Life Insurance Company 在第二季度將其在 Elevance Health 的持股提高了 30.7%。The Manufacturers Life Insurance Company 目前持有該公司 2,076,668 股股票，價值 807,741,000 美元，在上個季度額外購買了 487,579 股。89.24% 的股票由機構投資者持有。</p>
</div><h2>Elevance Health Price Performance</h2>
<div class="lb-trans"><h2>Elevance Health 價格表現</h2>
</div><p>Elevance Health stock opened at $372.80 on Monday. The company's 50 day moving average is $338.20 and its two-hundred day moving average is $327.98. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. The firm has a market cap of $82.85 billion, a PE ratio of 15.24, a price-to-earnings-growth ratio of 1.92 and a beta of 0.51. Elevance Health, Inc. has a 52-week low of $273.71 and a 52-week high of $458.75.</p>
<div class="lb-trans"><p>Elevance Health 股票週一開盤價為 372.80 美元。該公司的 50 日移動平均線為 338.20 美元，200 日移動平均線為 327.98 美元。該公司的速動比率為 1.56，流動比率為 1.56，債務與股本比率為 0.71。該公司的市值為 828.5 億美元，市盈率為 15.24，市盈增長比率為 1.92，貝塔值為 0.51。Elevance Health, Inc. 的 52 周低點為 273.71 美元，52 周高點為 458.75 美元。</p>
</div><ul>
<li>Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>防禦性投資：3 家支付股息的公司報告強勁的第三季度收益</li>
</ul>
</div><p>Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings results on Tuesday, October 21st. The company reported $6.03 earnings per share for the quarter, beating analysts' consensus estimates of $5.03 by $1.00. Elevance Health had a return on equity of 16.17% and a net margin of 2.84%.The company had revenue of $50.09 billion for the quarter, compared to analysts' expectations of $49.26 billion. During the same period last year, the firm earned $8.37 earnings per share. Elevance Health's quarterly revenue was up 12.0% on a year-over-year basis. On average, research analysts expect that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Elevance Health (NYSE:ELV - 獲取免費報告) 最近在 10 月 21 日星期二發佈了季度收益結果。該公司報告第三季度每股收益為 6.03 美元，超出分析師一致預期的 5.03 美元，超出幅度為 1.00 美元。Elevance Health 的股本回報率為 16.17%，淨利潤率為 2.84%。該公司第三季度的收入為 500.9 億美元，而分析師預期為 492.6 億美元。去年同期，該公司每股收益為 8.37 美元。Elevance Health 的季度收入同比增長 12.0%。研究分析師平均預計 Elevance Health, Inc. 本財年將發佈 33.96 的每股收益。</p>
</div><h2>Elevance Health Announces Dividend</h2>
<div class="lb-trans"><h2>Elevance Health 宣佈分紅</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Friday, December 5th were given a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Friday, December 5th. Elevance Health's dividend payout ratio (DPR) is presently 27.96%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了季度分紅，已於 12 月 19 日星期五支付。12 月 5 日星期五的股東獲得每股 1.71 美元的分紅。這相當於年化 6.84 美元的分紅和 1.8% 的股息收益率。除息日為 12 月 5 日星期五。Elevance Health 的分紅支付比率 (DPR) 目前為 27.96%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼 Centene 股票下跌 40% — 現在是否值得購買</li>
</ul>
</div><p>Several brokerages have recently commented on ELV. JPMorgan Chase &amp; Co. raised their price objective on shares of Elevance Health from $384.00 to $394.00 and gave the company an &#34;overweight&#34; rating in a research report on Tuesday, October 28th. Deutsche Bank Aktiengesellschaft reiterated a &#34;hold&#34; rating and issued a $320.00 price target (down from $332.00) on shares of Elevance Health in a report on Friday, December 19th. Wolfe Research set a $425.00 price target on Elevance Health and gave the stock an &#34;outperform&#34; rating in a research report on Thursday. Mizuho set a $413.00 price target on shares of Elevance Health in a research report on Friday. Finally, Morgan Stanley cut their price target on shares of Elevance Health from $359.00 to $352.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Wednesday, December 17th. Thirteen investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $400.85.</p>
<div class="lb-trans"><p>幾家券商最近對 ELV 發表了評論。摩根大通將 Elevance Health 的目標價從 384.00 美元上調至 394.00 美元，並在 10 月 28 日的研究報告中給予該公司 “增持” 評級。德意志銀行重申了 “持有” 評級，並在 12 月 19 日的報告中將 Elevance Health 的目標價設定為 320.00 美元（低於 332.00 美元）。Wolfe Research 將 Elevance Health 的目標價設定為 425.00 美元，並在週四的研究報告中給予該股票 “跑贏大盤” 評級。瑞穗證券在週五的研究報告中將 Elevance Health 的目標價設定為 413.00 美元。最後，摩根士丹利在 12 月 17 日的研究報告中將 Elevance Health 的目標價從 359.00 美元下調至 352.00 美元，並對該股票給予 “持平” 評級。十三位投資分析師對該股票給予了買入評級，十一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com，該股票目前的共識評級為 “持有”，共識目標價為 400.85 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Elevance Health</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 Elevance Health 股票分析</strong></p>
</div><h2>Elevance Health Profile</h2>
<div class="lb-trans"><h2>Elevance Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.</p>
<div class="lb-trans"><p>Elevance Health, Inc NYSE: ELV 是一家總部位於美國的大型健康福利公司，提供廣泛的健康保險產品和相關服務。公司總部位於印第安納波利斯，2022 年從 Anthem, Inc 更名為 Elevance Health，同時繼續以既有的州和國家品牌運營面向消費者的健康計劃。Gail Boudreaux 擔任首席執行官和總裁，領導公司在綜合醫療和福利交付方面的戰略重點。</p>
</div><p>Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.</p>
<div class="lb-trans"><p>Elevance 的核心業務包括為個人、僱主和政府項目（包括 Medicare 和 Medicaid 管理醫療產品）提供醫療和專業健康計劃。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Elevance Health</li>
<li>Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026</li>
<li>Shots officially fired…</li>
<li>Do not delete, read immediately</li>
<li>Trump Planning to Use Public Law 63-43: Prepare Now</li>
<li>Huge robotics rollout underway</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Elevance Health</li>
<li>華爾街 “潛力股” 可能成為 2026 年的第一隻股票</li>
<li>開火正式開始……</li>
<li>請勿刪除，立即閲讀</li>
<li>特朗普計劃使用公共法 63-43：請做好準備</li>
<li>巨大的機器人推廣正在進行中</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ELV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Elevance Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Elevance Health 嗎？</h2>
</div><p>Before you consider Elevance Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Elevance Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elevance Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛市場注意到之前購買的股票……而 Elevance Health 並不在名單上。</p>
</div><p>While Elevance Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Elevance Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Meeder Asset Management Inc. 購入了 15,825 股 Elevance Health, Inc.的股票 $ELV